1. Bhopal R. Glossary of terms relating to ethnicity and race: for reflection
and debate. J Epidemiol Community Health 2004; 58: 441–445.
2. Health Survey for England. The Health of Minority Ethnic Groups. NHS
Health and Social Care Information Centre, Public Health Statistics 2004.
Available from URL: http://www.ic.nhs.uk. Accessed 27 June 2007.
3. Ogden CL, Carrol MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM.
Prevalence of overweight and obesity in the United States, 1999–2004.
JAMA 2006; 295: 1549–1555.
4. Parikh M, Lo H, Chang C, Collings D, Fielding G, Ren C. Comparison of
outcomes after laparoscopic adjustable gastric banding in African-
Americans and whites. Surg Obes Relat Dis 2006; 2: 607–610.
5. Kumanyika SK, Obarzanek E, Stevens VJ, Hebert PR, Whelton PK. Weightloss
experience of black and white participants in NHLBI-sponsored clinical
trials. Am J Clin Nutr 1991; 53: 1631S–1638S.
6. Buffington CK, Marema RT. Ethnic differences in obesity and surgical
weight loss between African-American and Caucasian females. Obes
Surg 2006; 16: 159–165.
7. Hong K, Li Z, Wang H-J, Elashoff R, Heber D. Analysis of weight loss
outcomes using VLCD in black and white overweight and obese women
with and without metabolic syndrome. Int J Obes 2005; 29: 436–442.
8. Wing RR, Anglin K. Effectiveness of a behavioural weight control program
for blacks and whites with NIDDM. Diabetes Care 1996; 19: 409–413.
9. McMahon FG, Fujioka K, Singh BN et al. Efficacy and safety of sibutramine
in obese white and African American patients with hypertension. Arch
Intern Med 2000; 160: 2185–2191.
10. Neel JV, Weder AB, Julius S. Type II diabetes, essential hypertension, and
obesity as ‘‘syndromes of impaired genetic homeostasis’’: the ‘‘thrifty
genotype’’ hypothesis enters the 21st century. Perspect Biol Med 1998;
42: 44–74.
11. Bower JF, Vadlamudi S, Barakat HA. Ethnic differences in in-vitro glyceride
synthesis in subcutaneous and omental adipose tissue. Am J Physiol
Endocrinol Metab 2002; 283: E988–E993.
12. Bower J, Deshaies Y, Pfeifer M, Tanenberg RJ, Barakat HA. Ethnic differences
in post-prandial triglyceride response to a fatty meal and lipoprotein
lipase in lean and obese African American and Caucasian women.
Metabolism 2002; 51: 211–217.
13. Privette JD, Hickner RC, Macdonald KG, Pories WJ, Barakat HA. Fatty acid
oxidation by skeletal muscle homogenates from morbidly obese black
and white American women. Metabolism 2003; 52: 735–738.
14. Nicklas BJ, Berman DM, Davis DC, Dobrovolny CL, Dennis KE. Racial
differences in metabolic predictors of obesity among postmenopausal
women. Obes Res 1999; 7: 463–468.
15. Desmond SM, Price JH, Hallinan C, Smith D. Black and white adolescents’
perceptions of their weight. J Sch Health 1989; 59: 353–358.
16. Rand CS, Kuldau JM. The epidemiology of obesity and self-defined weight
problem in the general population. Gender, race, age, and social class. Int
J Eat Disord 1990; 9: 329–343.
17. Kahn HS, Williamson DF, Stevens JA. Race and weight change in US
women: the roles of socioeconomic and marital status. Am J Public
Health 1991; 81: 319–323.
18. Kumanyika S, Wilson JF, Guilford-Davenport M. Weight related attitudes
and behaviors of black women. J Am Diet Assoc 1993; 93: 416–422.
19. National Institute of Health and Clinical Excellence. Obesity: the prevention,
identification, assessment and management of overweight and obesity in
adults and children. Full guideline (2006), reference CG43. Available from
URL: http://www.nice.org.uk/guidance/index. Assessed 18 December
2007.
20. National Heart, Lung, and Blood Institute (NHLBI). Clinical guidelines on
the identification, evaluation and treatment of overweight and obesity in
adults: the evidence report. Obes Res 1998; 6(Suppl. 2): 51S–209S.
21. Bray GA. Medications for obesity: mechanisms and applications. Clin Chest
Med 2009; 30: 525–538.
22. Padwal R, Li SK, Lau DCW. Long-term pharmacotherapy for overweight and
obesity: a systematic review and meta-analysis of randomized controlled
trials. Int J Obes 2003; 27: 1437–1446.
23. Rucker D, Padwal R, Li SK, Curioni C, Lau DC. Long-term pharmacotherapy
for obesity and overweight: updated meta-analysis. BMJ 2007; 335:
1194–1199. doi:10:1136/bmj.39385.413113.25.
24. Douketis JD, Macie C, Thabane L, Williamson DF. Systematic review of
long term weight loss studies in obese adults: clinical significance and
applicability to clinical practice. Int J Obes 2005; 29: 1153–1167.
25. Glenny AM, O’Meara S, Melville A, Sheldon TA, Wilson C. The treatment
and prevention of obesity: a systematic review of the literature. Int J Obes
1997; 21: 715–737.
26. O’Meara S, Riemsma R, Shirran L,Mather L, ter Riet G. A systematic review
of the clinical effectiveness of orlistat used for themanagement of obesity.
Obes Rev 2004; 5: 51–68.
27. Avenell A, Broom J, Brown TJ et al. Systematic review of the long-term
effects and economic consequences of treatments for obesity and
implications for health improvement. Health Technol Assess 2004; 8:
iii–iv, 1–182.
28. PRISMA Statement. Available from URL: http://www.prisma-statement.
org. Accessed 27 August 2010.
29. Verhagen AP, de Vet HC, de Bie RA et al. The Delphi list: a criteria list for
quality assessment of randomized clinical trials for conducting systematic
reviews developed by Delphi consensus. J Clin Epidemiol 1998; 51:
1235–1241.
30. Juni P, Smith GD, Altman DG. Assessing the quality of randomised
controlled trials. In: Egger M, Smith GD, Altman DG eds. Systematic
Reviews in Health Care, 2nd edn. London: BMJ Publishing Group, 2001;
87–108.
31. STATSDIRECT Statistical Software version 2.6.6, StatsDirect Ltd, Cheshire, UK.
Available from URL: http//www.statsdirect.com. Accessed 2008/2009.
32. Egger M, Davey GS, Schneider M, Minder C. Bias in meta-analysis detected
by a simple, graphical test. Br Med J 1997; 315: 629–634.
33. Ades AE, Higgins JPT. The interpretation of random-effects meta-analysis
in decision models. Med Decis Making 2005; 25: 646–654.
34. McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K.,
Sibutramine in Hypertensives Clinical Study Group. Sibutramine is safe
and effective for weight loss in obese patients whose hypertension is
well controlled with angiotensin-converting enzyme inhibitors. J Hum
Hypertens 2002; 16: 5–11.
35. Dujovne CA, Zavoral JH, Rowe E, Mendel CM., Sibutramine Study Group.
Effects of sibutramine on body weight and serum lipids: a double-blind,
randomized, placebo controlled study in 322 overweight and obese
patients with dyslipidemia. Am Heart J 2001; 142: 489–497.
36. Fujioka K, Seaton TB, Rowe E et al. Sibutramine/Diabetes Clinical Study
Group. Weight loss with sibutramine improves glycaemic control and
other metabolic parameters in obese patients with type 2 diabetes
mellitus. Diabetes Obes Metab 2000; 2: 175–187.
37. Porter JA, Raebel MA, Conner DA et al. The Long-term Outcomes of
Sibutramine Effectiveness on Weight (LOSE Weight) Study: evaluating
the role of drug therapy within a weight management program in a
group-model health maintenance organization. Am J Manag Care 2004;
10: 369–376.
38. Wadden TA, Berkowitz RI, Womble LG et al. Randomized trial of lifestyle
modification and pharmacotherapy for obesity. N Engl J Med 2005; 353:
2111–2120.
39. Poston WSC, Haddock CK, Pinkston MM et al. Evaluation of a primary
care-oriented brief counselling intervention for obesity with and without
orlistat. J Intern Med 2006; 260: 388–398.
40. Poston WSC, Reeves RS, Haddock CK et al. Weight loss in obese Mexican
Americans treated for 1-year with orlistat and lifestyle modification. Int
J Obes 2003; 27: 1486–1493.
41. Garcia JM, Iyer D, Poston WSC et al. Rise of plasma ghrelin with weight
loss is not sustained during weight maintenance. Obesity 2006; 14:
1716–1722.
42. Davidson MH, Hauptman J, DiGirolamo M et al. Weight control and risk
factor reduction in obese subjects treated for 2 years with Orlistat: a
randomized controlled trial. JAMA 1999; 281: 235–242.
43. Dixon AN, Valsamakis G, Hanif MW et al. Effect of the orlistat on
serum endotoxin lipo-polysaccharide and adipocytokines in South Asian
individuals with impaired glucose tolerance. Int J Clin Pract 2008; 62:
1124–1129.
44. Hauptman J, Lucas C, Boldrin MN, Collins H, Segal KR., Orlistat Primary Care
Study Group. Orlistat in the long-term treatment of obesity in primary care
settings. Arch Fam Med 2000; 9: 160–167.
45. Heymsfield SB, Segal KR, Hauptman J et al. Effects of weight loss with
Orlistat on glucose tolerance and progression to type 2 diabetes in obese
adults. Arch Intern Med 2000; 160: 1321–1326.
46. Hill JO, Hauptman J, Anderson JW et al. Orlistat, a lipase inhibitor, for
weight maintenance after conventional dieting: a 1-y study. Am J Clin
Nutr 1999; 69: 1108–1116.
47. Hollander PA, Elbein SC, Hirsch IB et al. Role of orlistat in the treatment
of obese patients with type 2 diabetes: a randomized double-blind study.
Diabetes Care 1998; 21: 1299–1294.
48. Kelley DE, Bray GE, Pi-Sunyer FX et al. Clinical efficacy of Orlistat therapy
in overweight and obese patients with insulin-treated type 2 diabetes.
Diabetes Care 2002; 25: 1033–1041.
49. Miles JM, Letter L, Hollander P et al. Effect of Orlistat in overweight and
obese patients with type 2 diabetes treated with metformin. Diabetes
Care 2002; 25: 1123–1128.
50. Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA. Orlistat for
overweight subjects with nonalcoholic steatohepatitis: a randomized
prospective trial. Hepatology 2009; 49: 80–86.
51. Hussain-Gambles M. Ethnic minority under-representation in clinical trials.
J Health Organ Manag 2003; 17: 138–143.
52. Kumanyika SK, Morssink CB. Cultural appropriateness of weight management
programs. In: Dalton S ed. Overweight and Weight Management.
Gaithersburg, MD: Aspen, 1997; 69–106.
53. European Medicines Agency (EMA) updates on ongoing safety review of
sibutramine: weight lossmedicines assessed over cardiovascular concerns.
Available from URL: http://www.ema.europa.eu/pdfs/general/direct/
pr/81787609.pdf. Accessed 2010.
54. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of
Interventions Version 5.0.2. The Cochrane Collaboration, 2009. Available
from URL: http://www.cochrane-handbook.org. Accessed September
2009.